Basic Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Jan 15, 2004; 10(2): 244-249
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.244
Figure 8
Figure 8 Effect of administration time on inhibitory efficiency of HCV363a in HepG2. 9706. Phosphorothioate ODN (HCV363a) was dissolved in DMEM at various concentrations (0.2 μmol/L, 0.4 μmol/L, 0.8 μmol/L) and complexed with li-posome18-gal (octadecanol-galactoside:DC-chol:DOPE 1:6:4) at a ratio of 1:5 (wt/wt). HepG2.9706 cells were consecutively treated 3 times with HCV363a/18-gal complexes and the ac-tivity of luciferase enzyme was determined each time 24 h af-ter HCV363a/18-gal complexes was administered. Each value represents -x±s (n = 3).